Related Experiment Videos
Free fatty acids, central nervous system and bromazepam
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|January 1, 1982
Summary
Bromazepam significantly decreases plasma free fatty acid concentrations in healthy individuals. This effect was observed during a three-day administration period and persisted after discontinuation.
Area of Science:
- Pharmacology
- Biochemistry
- Clinical Medicine
Background:
- Free fatty acids (FFAs) are crucial energy substrates.
- Bromazepam is a benzodiazepine anxiolytic.
- Understanding drug effects on lipid metabolism is important.
Purpose of the Study:
- To investigate the impact of bromazepam on plasma FFA concentrations.
- To evaluate the duration of this effect after drug cessation.
Main Methods:
- Plasma FFA levels were measured in 33 subjects before and after 72 hours of bromazepam administration (6 mg/day).
- A control group (12 subjects) received a placebo.
- Measurements were taken at baseline, 24h, 72h during treatment, and 72h post-treatment.
Main Results:
- Bromazepam administration led to a significant decrease in plasma FFA levels (p<0.05, p<0.05, p<0.001).
- No significant changes in FFA levels were observed in the placebo group (p>0.05).
Conclusions:
- Three-day oral administration of bromazepam effectively reduces plasma free fatty acid concentrations.
- The observed reduction in FFAs suggests a potential impact of bromazepam on lipid metabolism.